Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CORZ | Duchene Todd M | See remarks | 10/26/2026 | Verkauf | 13.80 | 5,500 | 75,900 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/26/2026 | Verkauf | 13.27 | 4,500 | 59,694 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/19/2026 | Verkauf | 13.87 | 10,000 | 138,744 | Form 4 |
| CORZ | Sullivan Adam Taylor | Chief Executive Officer | 10/16/2026 | Steuer-Abgabe | 14.46 | 21,839 | 315,683 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/16/2026 | Steuer-Abgabe | 14.46 | 6,382 | 92,252 | Form 4 |
| CORT | Wilson James N | Director | 10/15/2026 | Verkauf | 116.30 | 300 | 34,889 | Form 4 |
| CORT | Wilson James N | Director | 10/15/2026 | Verkauf | 115.39 | 3,046 | 351,476 | Form 4 |
| CORT | Wilson James N | Director | 10/15/2026 | Verkauf | 114.48 | 6,654 | 761,717 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/12/2026 | Verkauf | 15.12 | 10,000 | 151,160 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/05/2026 | Verkauf | 16.31 | 10,000 | 163,056 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 10/02/2026 | Verkauf | 116.59 | 5,147 | 600,063 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 10/02/2026 | Verkauf | 115.73 | 2,086 | 241,412 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 10/02/2026 | Verkauf | 114.52 | 1,100 | 125,973 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 10/02/2026 | Optionsausübung | 21.63 | 8,333 | 180,243 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/02/2026 | Verkauf | 116.54 | 4,744 | 552,869 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/02/2026 | Verkauf | 115.70 | 4,446 | 514,389 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/02/2026 | Optionsausübung | 19.26 | 5,833 | 112,344 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/02/2026 | Optionsausübung | 13.56 | 3,357 | 45,521 | Form 4 |
| CORT | Maduck Sean | See Remarks | 10/02/2026 | Verkauf | 116.55 | 8,744 | 1,019,143 | Form 4 |
| CORT | Maduck Sean | See Remarks | 10/02/2026 | Verkauf | 116.12 | 15,843 | 1,839,741 | Form 4 |
| CORT | Maduck Sean | See Remarks | 10/02/2026 | Optionsausübung | 8.27 | 24,587 | 203,334 | Form 4 |
| CORZ | Sullivan Adam Taylor | Chief Executive Officer | 10/01/2026 | Steuer-Abgabe | 15.98 | 23,508 | 375,658 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 10/01/2026 | Steuer-Abgabe | 15.98 | 8,228 | 131,483 | Form 4 |
| COR | Krikorian Lazarus | SVP & Chief Accounting Officer | 10/01/2026 | Verkauf | 303.18 | 986 | 298,935 | Form 4 |
| COR | Sanchez Robert E | Director | 10/01/2026 | Zuteilung | — | 275 | — | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/01/2026 | Verkauf | 115.40 | 810 | 93,473 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 10/01/2026 | Optionsausübung | 13.56 | 810 | 10,984 | Form 4 |
| CORT | Maduck Sean | See Remarks | 10/01/2026 | Verkauf | 115.54 | 413 | 47,717 | Form 4 |
| CORT | Maduck Sean | See Remarks | 10/01/2026 | Optionsausübung | 8.27 | 413 | 3,416 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 09/28/2026 | Verkauf | 16.76 | 10,000 | 167,586 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 09/24/2026 | Schenkung | — | 5,000 | — | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 09/24/2026 | Schenkung | — | 17,100 | — | Form 4 |
| CORZ | Duchene Todd M | See remarks | 09/21/2026 | Verkauf | 18.37 | 10,000 | 183,746 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 09/17/2026 | Optionsausübung | 8.27 | 17,493 | 144,667 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/16/2026 | Verkauf | 100.82 | 296 | 29,843 | Form 4 |
| COR | Greenberg Lon R | Director | 09/16/2026 | Verkauf | 321.30 | 1,280 | 411,264 | Form 4 |
| CORZ | Weiss Eric Stanton | Director | 09/15/2026 | Kauf | 16.33 | 6,000 | 97,980 | Form 4 |
| CORT | Wilson James N | Director | 09/15/2026 | Verkauf | 111.70 | 2,800 | 312,771 | Form 4 |
| CORT | Wilson James N | Director | 09/15/2026 | Verkauf | 110.84 | 400 | 44,335 | Form 4 |
| CORT | Wilson James N | Director | 09/15/2026 | Verkauf | 110.27 | 6,800 | 749,835 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 09/14/2026 | Verkauf | 17.14 | 10,000 | 171,362 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 09/14/2026 | Verkauf | 114.12 | 2,188 | 249,686 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 09/14/2026 | Verkauf | 113.32 | 7,812 | 885,261 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 09/14/2026 | Optionsausübung | 13.56 | 7,404 | 100,398 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 09/14/2026 | Optionsausübung | 11.35 | 2,596 | 29,465 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 09/08/2026 | Verkauf | 18.67 | 10,000 | 186,735 | Form 4 |
| CORT | Maduck Sean | See Remarks | 09/02/2026 | Steuer-Abgabe | 113.38 | 117 | 13,265 | Form 4 |
| CORT | Mokari Atabak | Chief Financial Officer | 09/02/2026 | Steuer-Abgabe | 113.38 | 102 | 11,565 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 09/02/2026 | Steuer-Abgabe | 113.38 | 91 | 10,318 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 115.44 | 1,225 | 141,413 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 114.58 | 5,621 | 644,042 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 113.72 | 1,606 | 182,632 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 112.40 | 974 | 109,474 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 111.37 | 1,537 | 171,181 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 110.70 | 23,770 | 2,631,349 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Verkauf | 109.35 | 23,600 | 2,580,674 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Optionsausübung | 21.63 | 58,333 | 1,261,743 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/02/2026 | Steuer-Abgabe | 113.38 | 102 | 11,565 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 09/02/2026 | Steuer-Abgabe | 113.38 | 72 | 8,163 | Form 4 |
| CORT | Guyer William | Chief Development Officer | 09/01/2026 | Zuteilung | — | 164 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).